DaVita Inc.
DVA Healthcare Medical Care Facilities
DaVita Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.6 billion, up 6.46% from fiscal 2024. In the quarter to June 2026, revenue grew 5.17%, EPS grew 56.5%, free cash flow grew 49.4% and total debt rose 4.40%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.
Follow DVA
DaVita Inc. (DVA) P/B ratio
DaVita Inc. has no meaningful P/B ratio: its trailing twelve-month book value is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 38.1× (February 2025) — the current reading is the lowest in ten years.
P/B ratio, daily
Embed this chart
Annual newest first
| Period | P/B ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 32.1× | 311.60% |
| FY2023 | 7.8× | (1.82%) |
| FY2022 | 7.9× | (37.86%) |
| FY2021 | 12.8× | 42.45% |
| FY2020 | 9.0× | 81.14% |
| FY2019 | 5.0× | 120.38% |
| FY2018 | 2.2× | (19.70%) |
| FY2017 | 2.8× | 3.48% |
| FY2016 | 2.7× | (6.84%) |
Quarterly newest first
| Period | P/B ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 42 more quarters | Free account |
Against its own ten years
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| DVA DaVita Inc. | n/m |
| FMS Fresenius Medical Care AG & Co. KGaA compare | 0.8× |
| UHS Universal Health Services, Inc. compare | 1.5× |
| THC Tenet Healthcare Corporation compare | 3.4× |
| EHC Encompass Health Corporation compare | 3.7× |
| ENSG The Ensign Group, Inc. compare | 4.2× |
| PACS PACS Group, Inc. compare | 6.6× |
| CHE Chemed Corporation compare | 8.1× |
| CON Concentra Group Holdings Parent, Inc. compare | 9.9× |
| Medical Care Facilities industry median | 2.8× |
| Healthcare sector median | 2.3× |
| Market median | 1.7× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on DVA
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement